IUS2:XETRA:XETRA-iShares S&P U.S. Banks UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 6.306

Change

+0.15 (+2.44)%

Market Cap

USD 0.33B

Volume

0.07M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.01 (-0.03%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.01 (+0.06%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.05%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.11 (-0.38%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.06 (+0.22%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.07%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+0.32 (+0.22%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.05 (-0.10%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.76 (-0.71%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-6.12 (-1.00%)

USD 80.38B

ETFs Containing IUS2:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.16% 91% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.16% 91% A- 88% B+
Trailing 12 Months  
Capital Gain 38.44% 92% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.44% 92% A 90% A-
Trailing 5 Years  
Capital Gain 38.09% 65% D 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.09% 62% D 62% D
Average Annual (5 Year Horizon)  
Capital Gain 17.47% 89% A- 86% B+
Dividend Return 17.47% 88% B+ 84% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 36.93% 7% C- 14% F
Risk Adjusted Return 47.30% 43% F 49% F
Market Capitalization 0.33B 56% F 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.